Recent advances in childhood vasculitis.

Area of Science:

• Pediatric Rheumatology
• Immunology
• Genetics

Background:

• Vasculitis encompasses a group of rare inflammatory diseases affecting blood vessels.
• Understanding the genetic underpinnings and clinical presentations of vasculitis is crucial for effective management.
• Pediatric vasculitides present unique diagnostic and therapeutic challenges.

Purpose of the Study:

• To summarize recent findings in vasculitis with potential impact on understanding and management.
• To highlight advances in monogenic diseases mimicking pediatric vasculitis.
• To review new treatment strategies and diagnostic criteria.

Main Methods:

• Literature review of recent findings in vasculitis.
• Analysis of studies on monogenic disorders associated with vasculitis.
• Summary of new treatment reports and diagnostic criterion reassessments.

Main Results:

• Monogenic diseases like adenosine deaminase 2 deficiency and A20 haploinsufficiency mimic pediatric vasculitis.
• Genetic studies identified new risk loci for Behçet disease, confirming HLA-B-51 association.
• New treatment reports exist for Henoch-Schönlein purpura/Immunoglobulin A vasculitis, CNS vasculitis, and Takayasu disease.
• Diagnostic criteria for pediatric Behçet disease and ANCA-associated vasculitis have been reassessed.

Conclusions:

• New pathways in monogenic diseases may lead to targeted therapies for vasculitis.
• The rarity of pediatric vasculitis hinders large-scale studies, necessitating multicenter collaboration.
• Multicenter studies are essential for conclusive results in managing pediatric vasculitis.